Nadler Financial Group, Inc.

Position in GILD — Gilead Sciences, Inc.

CIK 1541787 DEERFIELD, IL

Position in GILD

as of Jun 30, 2026 · filed Jul 30, 2026 Compact

Position Value

$267,840

-$13,687 QoQ

Shares Held

2,120

+5.0% QoQ

Ownership

0.000%

of shares outstanding

% of Portfolio

0.16%

of 13F equity value

Holder Rank

#1,735

of 2,266 holders

Holding Since

Jun 2020

12 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Nadler Financial Group, Inc. holds $7,548,194 across 7 Drug Manufacturers - General names. GILD ranks #7 (3.5% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	LLY	ELI LILLY & Co	1,767	$2,119,392
2	ABBV	AbbVie Inc.	7,729	$1,944,925
3	JNJ	Johnson & Johnson	6,146	$1,560,899
4	MRK	Merck & Co., Inc.	6,005	$771,642
5	AMGN	Amgen Inc	1,389	$502,984
6	PFE	Pfizer Inc	15,802	$380,512
7	GILD	Gilead Sciences, Inc. This page	2,120	$267,840

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$267,840	2,120	+5.0%	Shares	Sole	2026-07-30
2026-03-31	$281,527	2,020	-0.1%	Shares	Sole	2026-05-04
2025-12-31	$248,180	2,022	+0.6%	Shares	Sole	2026-01-28
2025-09-30	$223,110	2,010	0.0%	Shares	Sole	2025-10-30
2025-06-30	$222,848	2,010	0.0%	Shares	Sole	2025-07-28
2025-03-31	$225,220	2,010	-23.9%	Shares	Sole	2025-04-24
2023-03-31	$219,040	2,640	0.0%	Shares	Sole	2023-04-19
2022-12-31	$226,644	2,640	-16.1%	Shares	Sole	2023-01-30
2021-12-31	$228,503	3,147	0.0%	Shares	Sole	2022-01-18
2021-09-30	$219,817	3,147	0.0%	Shares	Sole	2021-10-13
2021-06-30	$216,702	3,147	+16.9%	Shares	Sole	2021-07-16
2020-06-30	$207,122	2,692	—	Shares	Sole	2020-07-09
No filing history on record for this holder in this stock.